Kissei ordered to add warning over vasculitis drug after fatalities
Kissei Pharmaceutical has been ordered to add a warning label to its vasculitis drug following reports of fatalities. The decision comes after health authorities raised concerns about the drug's safety profile. This action aims to ensure that patients are adequately informed of the potential risks associated with the medication.
- ▪Kissei Pharmaceutical is required to add a warning label to its vasculitis drug.
- ▪The order follows reports of fatalities linked to the medication.
- ▪Health authorities are concerned about the drug's safety profile.
Opening excerpt (first ~120 words) tap to expand
var article_info = {"cms_article_id":641693,"is_old_article":0} ; .jt-top-article-details .article-print-logo{display: none;} .jt-top-article-details .article-section{text-transform: uppercase;margin: 10px 0 5px;font-family: 'Pluto Sans Bold', 'Helvetica Neue', Helvetica, Arial, sans-serif;font-size: 11px; line-height: 14px;color:#c8102e;} .jt-top-article-details .article-section h2{margin: 0px;} .jt-top-article-details .article-section a{color:#C8102E;} .jt-top-article-details .separator{color:#333;font-family: 'Neue Bold';font-size: 11px;line-height: 14px;} .jt-top-article-details .premium-label{background-color:#898989;color:#FFF;font-size: 9px;line-height:24px;padding: 1px 9px;margin-left:5px;font-weight:200;font-family:'Pluto Sans Regular', 'Helvetica Neue', Helvetica, Arial,…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Japan Times.
Discussion
0 commentsMore from Japan Times
